Form 8-K - Current report:
SEC Accession No. 0001193125-22-176256
Filing Date
2022-06-17
Accepted
2022-06-17 12:33:03
Documents
12
Period of Report
2022-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d318244d8k.htm   iXBRL 8-K 33278
  Complete submission text file 0001193125-22-176256.txt   159082

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20220615.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20220615_lab.xml EX-101.LAB 18758
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20220615_pre.xml EX-101.PRE 11725
6 EXTRACTED XBRL INSTANCE DOCUMENT d318244d8k_htm.xml XML 3508
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 221023046
SIC: 2834 Pharmaceutical Preparations